Sign in
4

Changes in Ownership

NEKTAR THERAPEUTICS Filed Acc 0001209191-19-057489

SVP, COO & CFO sold 8,863 shares at $17.97 ($159,268)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Labrucherie Gil M SVP, COO & CFO 2019-11-18 Sale −8,863 $17.97 $159,268 219,009 D: show line 1 in the form
Open-market sales · 8,863 sh · avg $17.97 · $159,268
Loading xslF345X03/doc4.xml…